The Challenge of Postoperative Infections: Does the Surgeon Make a Difference?

Infection Control and Hospital Epidemiology

Volumn 18, Issue 6, 1997, Pages 449-456

  Holzheimer, René G ^a   Haupt, Werner ^b   Thiede, Arnulf ^a   Schwarzkopf, Andreas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; CLASSIFICATION; HOSPITAL; HUMAN; INFECTION CONTROL; METHODOLOGY; REVIEW; RISK FACTOR; SURGERY; SURGICAL INFECTION;

ANTIBIOTIC PROPHYLAXIS; DRUG RESISTANCE, MICROBIAL; HOSPITALS; HUMANS; INFECTION CONTROL; RISK FACTORS; SURGERY; SURGICAL WOUND INFECTION;

EID: 0031156778     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141254     Document Type: Review

References (97)

1. Stone R. Search for sepsis drugs goes on despite past failures. Science 1994;264:365-367.
2. Green JW, Wenzel RP. Postoperative wound infection: a controlled study of the increased duration of hospital stay and direct cost of hospitalization. Ann Surg 1977;185:264-268.
3. Brewer GE. Studies in aseptic technique, with a report of some recent observations at the Roosevelt Hospital. JAMA 1915; 64:1369-1372.
4. Ehrenkranz NJ. Surgical wound infection occurrence in clean operations risk stratification for interhospital comparisons. Am J Med 1981;70:909-914.
5. Simchen E, Shapiro M, Michel J, et al. Multivariate analysis of determinants of postoperative wound infection: a possible basis for intervention. Rev Infect Dis 1981;3:678-682.
6. Nichols RL, Smith JW, Klein DB, et al. Risk of infection after penetrating abdominal trauma. N Engl J Med 1984;311: 1065-1070.
7. Cruse PJE, Foord R. A five-year prospective study of 23,649 surgical wounds. Arch Surg 1973;107:206-210.
8. Scheckler WE. Surgeon-specific wound infection rates - a potential dangerous and misleading strategy. Infect Control Hosp Epidemiol 1988;9:145-146.
9. Olson MM, Lee JT. Continuous, 10-year wound infection surveillance results, advantages, and unanswered questions. Arch Surg 1990;125:794-803.
10. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182-205.
11. Haley RW, Morgan WM, Culver DH, et al. Update from the SENIC project hospital infection control: recent progress and opportunities under prospective payment. Am J Infect Control 1985;13:97-108.
12. Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med 1991;91(suppl 3b):152-157.
13. Keats AS. The ASA classifications of the physical status - a recapitulation. Anesthesiology 1978;49:233-236.
14. Hooton TM, Haley RW, Culver DH, White JW, Morgan WM, Carroll RJ. The joint associations of multiple risk factors with the occurrence of nosocomial infection. Am J Med 1981;70:960-970.
15. Conklin CM, Gray RJ, Neilson D, Wong P, Tomita DK, Matloff JM. Determinants of wound infection incidence after isolated coronary artery bypass surgery in patients randomized to receive prophylactic cefuroxime or cefazolin. Ann Thorac Surg 1988;46:172-177.
16. Kaiser AB, Herrington IL, Jacobs JK, Mulherin JL, Roach AC, Sawyers JL. Cefoxitin versus erythromycin, neomycin, and cefazolin in colorectal operations. Ann Surg 1983;198:525-530.
17. Coppa GF, Eng K. Factors involved in antibiotic selection in elective colon and rectal surgery. Surgery 1988;104:853-858.
18. Haley RW, Culver DH, Morgan WM. Identifying patients at high risk of surgical wound infection: a simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol 1985;121:206-215.
19. Garibaldi RA, Cushing D, Lerer T. Risk factors for postoperative infection. Am J Med 1991;91(suppl 3b):158S-163S.
20. Thomson PD, Smith DJ. What is infection? Am J Surg 1995;167(suppl 1a):7S-11S.
21. Meakins JL. Prophylactic antibiotics. In: Meakins JL, ed. Surgical Infections - Diagnosis and Treatment. New York City, NY: Scientific American Medicine; 1994:139-149.
22. Cruse PJE. Wound infections: epidemiology and clinical characteristics. In: Howard RJ, Simmons RL, eds. Surgical Infectious Diseases. Norwalk, CT: Appleton and Lange; 1988:319-329.
23. Emmerson M. Environmental factors influencing infection. In: Taylor EW, ed. Infection in Surgical Practice. Oxford, England: Oxford Medical Publications; 1992:8-17.
24. Leaper DJ. Surgical factors influencing infection. In: Taylor EW, ed. Infection in Surgical Practice. Oxford, England: Oxford Medical Publications; 1992:18-27.
25. Gottrup F. Measurements and evaluation of tissue perfusion in surgery. In: Leaper DJ, Braniki FJ, eds. Infection in Surgical Practice. Oxford, England: Oxford University Press; 1992:15-39.
26. Lau WY, Fan ST, Chu KW. Influence of surgeon experience on postoperative sepsis. Am J Surg 1988;155:322-326.
27. Cuthbertson AM, McLeish AR, Penfold JC, Ross H. A comparison between single and double intravenous trimetin for prophylaxis of wound infection in colorectal surgery. Dis Colon Rectum 1991;34:151-155.
28. Misrhiki SF, Law DJW, Jeffrey PJ. Factors affecting the incidence of postoperative wound infection. J Hosp Infect 1990;16:223-230.
29. Browder W, Smith JW, Vivoda LM, Nichols RL. Nonperforative appendicitis: a continuing surgical dilemma. J Infect Dis 1989;159:1088-1094.
30. Christou NV, Nohr CS, Meakins JL. Assessing operative site infection in surgical patients. Arch Surg 1987;122:165-169.
31. Cainzos M, Alcalde JA, Potel J, Puente JL. Anergy in patients with gastric cancer. Hepatogastroenterology 1989;36:36-39.
32. Windsor ACJ, Klava AA, Somers SS, Guillou PJ, Reynolds JV. Manipulation of local and systemic host defense in the prevention of perioperative sepsis. Br J Surg 1995;82:1460-1467.
33. Chaudry ICH, Stephan RN, Harkema JM, Dean RE. Immunological alterations following simple hemorrhage. In: Faist E, Ninnemann JL, Green DR, eds. Immune Consequences of Trauma, Shock and Sepsis: Mechanisms and Therapeutic Approaches. Berlin, Germany: Springer-Verlag; 1989:363-373.
34. Ayala A, Perin MM, Chaudry ICH. Increased susceptibility to sepsis following hemorrhage: defective Kupffer-cell mediated antigen presentation. Surgical Forum 1989;40:102-104.
35. Redan JA, Rush BF, Machiedo GW, et al. Fate of bacteria absorbed from the gut during hemorrhagic shock. Surgical Forum 1989;40:91-93.
36. Baker JW, Deitch EA, Li M, Berg RD, Specian RD. Hemorrhagic shock induces bacterial translocation from the gut. J Trauma 1988;28:896-906.
37. Sori AJ, Rush BF, Lysz TW, Smith S, Maciedo GW. The gut as source of sepsis after hemorrhagic shock. Am J Surg 1988;155:187-192.
38. Rush BF, Sori AJ, Murphy TF, Smith S, Flanagan JJ, Machiedo GW. Endotoxemia and bacteremia during hemorrhagic shock. The link between trauma and sepsis? Ann Surg 1988;207:549-554.
39. Haley RW, Aber RC, Bennett JV. Surveillance of nosocomial infections. In: Bennett JV, Brachman PS, eds. Hospital Infections. 2nd ed. Boston, MA: Little Brown & Co; 1986:51-71.
40. Hughes JM. Nosocomial infection surveillance in the United States: historical perspective. Infect Control 1987;8:450-453.
41. Kislak JW, Eickhoff TC, Finland M. Hospital acquired infections and antibiotic usage in the Boston City Hospital, January 1964. N Engl J Med 1964;271:834-835.
42. Barrett FF, Casey JI, Finland M. Infections and antibiotic use among patients at Boston City Hospital, February 1967. N Engl J Med 1968;278:5-9.
43. Scheckler WE, Garner JS, Kaiser AB, et al. Prevalence of infections and antibiotic usage in eight community hospitals. In: Proceedings of the International Conference on Nosocomial Infections; August 1970; Atlanta, GA; pp 299-305.
44. Stamm WE, Martin SM, Bennett JV. Epidemiology of nosocomial infections due to gram-negative bacilli: aspects relevant to development and use of vaccines. J Infect Dis 1977;136: 151S-160S.
45. Centers for Disease Control. Nosocomial infection surveillance, 1984. In: Centers for Disease Control Surveillance Summaries. Atlanta, GA: Centers for Disease Control 1986;35:17SS-29SS.
46. Haley RW, White JW, Culver DH, et al. The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system: an empirical determination from a nationally representative sample. JAMA 1987;257:1611-1614.
47. Haley RW, Quade D, Freeman HE, et al. The SENIC project: study on the efficacy of nosocomial infection control (SENIC project). Am J Epidemiol 1980;111:472-485.
48. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182-205.
49. National Academy of Sciences National Research Council. Postoperative wound infections: the influence of ultraviolet irradiation of the operating room and of various other factors. Ann Surg 1960;160(suppl 2):1-132.
50. Haley RW, Culver DH, Morgan WM, et al. Identifying patients at risk of surgical wound infection: a simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol 1985;121:206-215.
51. Condon RE, Schulte WJ, Malangoni MA, et al. Effectiveness of a surgical wound surveillance program. Arch Surg 1983; 118:303-307.
52. Olson M, O'Connor M, Schwartz ML. Surgical wound infections: a 5-year prospective study of 20,193 wounds at the Minneapolis VA Medical Center. Ann Surg 1984;199:253-259.
53. Cruse PJE, Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980;60:2740.
54. Cruse P. Wound infection surveillance. Rev Infect Dis 1981; 3:734-737.
55. Condon RE, Haley RW, Lee JT, Meakins JL. Does infection control, control infection? Panel discussion - Surgical Infection Society, 1987. Arch Surg 1988;123:250-256.
56. Haley RW. Nosocomial infections in surgical patients: developing valid measures of intrinsic patient risk. Am J Med 1991;91(suppl 3b):145S-151S.
57. Moro ML, Jepsen OB, The EURO.NIS Study Group. Infection control practices in intensive care units of 14 European countries. Intensive Care Med 1996;22:872-879.
58. Brun-Buisson C. Practice guidelines for prevention of infection in European ICUs: a call for standards. Intensive Care Med 1996;22:847-848.
59. Rudolph H, Hilbert M. Infektionsstatistik. Hyg Med 1994;19:376-384. Editorial.
60. Miles AA, Miles EM, Burke J. The value and duration of defense reactions of the skin to the primary lodgment of bacteria. Br J Exp Pathol 1957;38:79-96.
61. Burke JK. The effective period of preventing antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50:161-168.
62. Polk HC, Lopez-Mayor JF. Postoperative wound infection: a prospective study of determinant factors and prevention. Surgery 1969;66:97-103.
63. Polk HC. Contributions of alimentary tract surgery to modern infection control. Am J Surg 1987;153:2-8.
64. Jones RN, Wojeski W, Bakke J, Porter C, Searies M. Antibiotic prophylaxis of 1,036 patients undergoing elective surgical procedures. A prospective, randomized comparative trial of cefazolin, cefoxitin, and cefotaxime in a prepaid medical practice. Am J Surg 1987;153:341-346.
65. Nichols RL. Surgical infections: prevention and treatment -1965 to 1995. Am J Surg 1996;172:68-74.
66. Platt R, Zaleznik DF, Hopkins CC, et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med 1990;332:153-160.
67. Leaper DJ. Prophylactic and therapeutic role of antibiotics in wound care. Am J Surg 1994;167(suppl 1a):15S-20S.
68. Bannister GC. Infections in hip and knee prostheses. Curr Opin Orthop 1991;2:65-68.
69. Karran SJ, Sutton G, Gartell P, et al. Imipenem prophylaxis in elective colorectal surgery. Br J Surg 1993;80:1196-1198.
70. Nichols RL. Surgical infections: prevention and treatment -1965 to 1995. Am J Surg 1996;172:68-74.
71. Archer GL, Armstrong BC. Alteration of staphylococcal flora in cardiac surgery patients receiving prophylaxis. J Infect Dis 1983;147:642-649.
72. Avery CM, Jamieson NV, Calne RY. Administration of heparin and antibiotic prophylaxis. Br J Surg 1994;81:987-988.
73. Rüden H, Daschner F, Schumacher M. Nosokomiale Infektionen in Deutschland: Erfassung und Prävention (NIDEP-Studie). Teil 1: Prävalenz nosokomialer Infektionen; Qualitätssicherung in der Krankenhaushygiene. Ed. Bundesministerium für Gesundheit. Baden, Germany: Nomos Verlag Baden; 1995.
74. Bauer T, Vennits BO, Holm B, et al. Antibiotic prophylaxis in acute nonperforated appendicitis. Ann Surg 1989;62:307-311.
75. Gorbach SL. Antibiotic prophylaxis for appendectomy and colorectal surgery. Rev Infect Dis 1991;13(suppl 10):815S-820S.
76. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlore RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med 1992;326:281-286.
77. Neu HC. Emergence and mechanisms of bacterial resistance in surgical infections. Am J Surg 1995;169(suppl 5a):13S-20S.
78. Low DE, Willey BM, Betschel S, Kreiswirth B. Enterococci: pathogens of the 90's. Eur J Surg 1994;573(suppl):19-24.
79. Jones RN. Gram-positive superinfections following β-lactam chemotherapy: the significance of the enterococcus. Infection 1985;13:581-588.
80. Leoung GS, Chaisson RE, Mills J. Comparison of nosocomial infections due to Staphylococcus aureus and enterococci in a general hospital. Surg Gynecol Obstet 1987;165:339-342.
81. Wells VD, Wong ES, Murray BE, Coudron PE, Williams DS, Markowitz SM. Infections due to β-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis. Ann Intern Med 1992;116:285-292.
82. Zervos MJ, Bacon AE, Patterson JE, Schaberg DR, Kauffman CA. Enterococcal superinfections in patients treated with ciprofloxacin. J Antimicrob Chemother 1988;21:113-115.
83. Berkelman RL, Bryan RT, Osterholm MT, LeDuc JW, Hughes JM. Infectious disease surveillance: a crumbling foundation. Science 1994;264:368-370.
84. Holzheimer RG, Quoika P, Pätzmann D, Füssle R. Nosocomial infections in general surgery: surveillance report from a German university clinic. Infection 1990;18:219-225.
85. Feliciano DV, Gentry LO, Bitondo CG, et al. Single-agent cephalosporin prophylaxis for penetrating abdominal trauma. Results and comment on the emergence of the enterococcus. Am J Surg 1986;152:674-681.
86. Yu V. Enterococcal superinfections and colonization after therapy with moxalactam, a new broad-spectrum antibiotic. Ann Intern Med 1981;94:784-785.
87. Zervos M. Vancomycin-resistant Enterococcus faecium infections in the ICU and quinupristin/dalfopristin. New Horiz 1996;4:385-392.
88. Kingman S. Resistance a European problem, too. Science 1994;264:363-365.
89. Finland M, McGowan JE. Nosocomial infections in surgical patients. Arch Surg 1976;111:143-145.
90. Barber M. Reversal of antibiotic resistance to hospital staphylococcal infections. Br Med J 1960;1:11-17.
91. Chavigny KH, Fischer J. Competing risk factors with nosocomial infection in two university hospitals. J Hosp Infect 1984;5(suppl A):57-62.
92. Drusano GL. Role of pharmacokinetics in the outcome of infections. Antimicrob Agents Chemother 1988;32:289-297.
93. Neu H. Emerging trends in antimicrobial resistance in surgical infections. Eur J Surg 1994;573(suppl):7-18.
94. Moellering RC. Past, present and future of antimicrobial agents. Am J Med 1995;99(suppl 6a):11S-18S.
95. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994;264:375-382.
96. Tomasz A. Multiple antibiotic-resistant pathogenic bacteria. A report from the Rockefeller University workshop. N Engl J Med 1994;330:1247-1251.
97. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996;275:234-240